3 results
Approved WMOCompleted
Part I (single ascending dose):To evaluate the safety and tolerability of ascending single doses of DRL-17822 in healthy male subjects;To evaluate the pharmacokinetics of ascending single doses of DRL-17822 in healthy male subjects;To determine CETP…
Approved WMOCompleted
To determine the safety, tolerability and pharmacokinetics of an 18-hour i.v. infusion of CLR325 in stable heart failure patients.
Approved WMORecruiting
The overall objective of this proposal is to implement a digital care platform to monitor rheumatoid artritis disease activity between scheduled rheumatologist visits over 12 months. The essential components in this system are as follows: (1) the…